Recombinant CD28 (Lulizumab Biosimilar) antibody
The Humanized Chimeric anti-CD28 (Lulizumab Biosimilar) antibody is suitable to detect CD28 (Lulizumab Biosimilar) in samples from Human.
Catalog No. ABIN7597801
$488.65
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant CD28 (Lulizumab Biosimilar) antibody (ABIN7597801)
Target
CD28 (Lulizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Lulizumab Biosimilar Antibody
-
Specificity
- CD28, TP44, T-cell-specific surface glycoprotein CD28
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- Kappa
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.51 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- CD28 (Lulizumab Biosimilar)
-
Alternative Name
- Lulizumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- CD28, TP44, T-cell-specific surface glycoprotein CD28
-
UniProt
- P10747
Target
-
You are here:
